FDA news - the latest biotech news from Labiotech.eu

Home FDA

Latest Posts

Trump’s healthcare cabinet picks: Implications for U.S. biopharma

News and Trends 29 Nov 2024

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.?

November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

Niemenn Pick disease

News and Trends 2 Oct 2024

Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

October 2, 2024 - 7 minutesmins - By Willow Shah-Neville

The crucial role of rapid toxicology material delivery

Sponsored by 10 Sep 2024

Accelerating the path to clinical filing applications with rapid toxicology material delivery

Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials.

September 10, 2024 - 8 minutesmins - By Alexander Burik

Ipsen loses court case

News and Trends 13 Aug 2024

Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry?

Ipsen has lost a court case against U.S. regulators to have its blockbuster cancer medication Somatuline Depot regarded as a biologic instead of a drug.

August 13, 2024 - 4 minutesmins - By Roohi Mariam Peter

Gilead's Lenacapavir

In Depth 18 Jul 2024

Lenacapavir: Can Gilead’s drug end the HIV pandemic?

Discover more about Gilead’s lenacapavir, which recently demonstrated 100% efficacy for HIV prevention in a phase 3 trial.

July 18, 2024 - 7 minutesmins - By Willow Shah-Neville

drug approvals 2024

In Depth 27 Jun 2024

The 2024 drug approval list: Eight new treatments you should know about

In this article, we take a look at eight much-anticipated drugs that have been approved by regulators so far this year.

June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter

ADVERTISEMENT

IgA nephropathy

In Depth 15 May 2024

Drugs for IgA nephropathy on the rise in the clinic

As we observed IgA Nephropathy Awareness Day on May 14th, let us take a look at ongoing clinical trials for drugs that aim to make patient lives better.

May 15, 2024 - 9 minutesmins - By Roohi Mariam Peter

pulmonary hypertension treatment

In Depth 8 May 2024

New treatment for pulmonary hypertension: what biotech holds in store?

While it has been about managing pulmonary hypertension’s symptoms for a long time, new treatments are adressing the root of the disease.

May 8, 2024 - 8 minutesmins - By Jules Adam

alchemyrefiner alchemymagic 3 04e4a427 d1fa 4258 9dab 2690330368fd 0

Podcast 19 Apr 2024

The biotech investment landscape in 2024

Dive into 2024’s biotech investment strategies with RTW Investments on our podcast. Discover trends shaping the landscape ahead.”

April 19, 2024

FDA drug trials

In Depth 15 Apr 2024

Does the FDA need to tighten its grip on drug trials in the U.S.?

Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process.

April 15, 2024 - 8 minutesmins - By Roohi Mariam Peter

FDA investigator

Expert Advice 5 Apr 2024

How to build a career as an investigator at the FDA?

Discover the role and implications of an FDA investigator, a career of high responsibility and challenges, from qualifications to application.

April 5, 2024 - 7 minutesmins - By Jules Adam

CAR T therapy companies

Best in Biotech 21 Mar 2024

Eight CAR-T cell therapy companies you should know about

Discover eight promising biotech companies that are advancing their CAR T cell therapy candidates in the clinic.

March 21, 2024 - 9 minutesmins - By Roohi Mariam Peter

ADVERTISEMENT